Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
Elbarouni B, Ismaeil N, Yan RT, Fox KA, Connelly KA, Baer C, DeYoung JP, Gallo R, Ramanathan K, Pesant Y, Leiter LA, Goodman SG, Yan AT. Elbarouni B, et al. Among authors: connelly ka. Am Heart J. 2011 Aug;162(2):347-355.e1. doi: 10.1016/j.ahj.2011.05.020. Epub 2011 Jul 20. Am Heart J. 2011. PMID: 21835297 Clinical Trial.
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management.
Mancini GB, Cheng AY, Connelly K, Fitchett D, Goldenberg R, Goodman SG, Leiter LA, Lonn E, Paty B, Poirier P, Stone J, Thompson D, Yale JF. Mancini GB, et al. Can J Cardiol. 2017 Mar;33(3):366-377. doi: 10.1016/j.cjca.2016.07.512. Epub 2016 Jul 26. Can J Cardiol. 2017. PMID: 28340996 Review.
Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
Grenier J, Leiter LA, Langer A, Goldin L, Teoh H, Connelly KA, Cheng AYY, Tan MK, Fitchett D, McGuire DK, Goodman SG, Yan AT. Grenier J, et al. Among authors: connelly ka. Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):277-284. doi: 10.1093/ehjqcco/qcw013. Eur Heart J Qual Care Clin Outcomes. 2016. PMID: 29474711
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA. Verma S, et al. Among authors: connelly ka. Circulation. 2019 Nov 19;140(21):1693-1702. doi: 10.1161/CIRCULATIONAHA.119.042375. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434508 Clinical Trial.
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials.
Ghosh-Swaby OR, Goodman SG, Leiter LA, Cheng A, Connelly KA, Fitchett D, Jüni P, Farkouh ME, Udell JA. Ghosh-Swaby OR, et al. Among authors: connelly ka. Lancet Diabetes Endocrinol. 2020 May;8(5):418-435. doi: 10.1016/S2213-8587(20)30038-3. Lancet Diabetes Endocrinol. 2020. PMID: 32333878
Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey.
Nouraei H, Leiter LA, Tan MK, Langer A, Teoh H, Cheng AYY, Wald R, Connelly KA, Goodman SG, Yan AT. Nouraei H, et al. Among authors: connelly ka. Can J Diabetes. 2021 Dec;45(8):743-749. doi: 10.1016/j.jcjd.2021.02.003. Epub 2021 Feb 24. Can J Diabetes. 2021. PMID: 33839025
343 results